In conclusion, our results demonstrate that low dose gemcitabine treatment can cause the changes of protein kinases, phosphatases and the corresponding signaling pathways, which may play important roles to induce stem cell characteristics in pancreatic cancer cells. Here, WEE1 is linked to familial pancreatic carcinoma.